Table 1 Characteristics of publications on benzodiazepine and Z-drug discontinuation in community dwelling adults
From: Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Characteristic | No. | % of 139 articles |
|---|---|---|
Type of article | Â | Â |
Original research | Â | Â |
 Randomized-controlled trial | 52 | 37.4 % |
 Before-after study | 8 | 5.8 % |
 Nonrandomized controlled trial | 6 | 4.3 % |
 Systematic review/meta-analysis | 3 | 2.2 % |
 Prospective cohort study | 2 | 1.4 % |
 Non-comparative study | 2 | 1.4 % |
 Retrospective cohort study | 1 | 0.7 % |
Non-original research | Â | Â |
 Narrative review | 58 | 41.7 % |
 Guideline | 7 | 5.0 % |
Country of origin | Â | Â |
 United States | 38 | 27.3 % |
 United Kingdom | 33 | 23.7 % |
 Europe | 24 | 17.3 % |
 Canada | 20 | 14.4 % |
 Australia | 13 | 9.4 % |
 Asia | 2 | 1.4 % |
 Other | 9 | 6.5 % |
Year of publication | Â | Â |
 <1985 | 4 | 2.9 % |
 1985–1994 | 50 | 36.0 % |
 1995–2004 | 40 | 28.8 % |
 2005–2015 | 45 | 32.4 % |
Primary medical condition | Â | Â |
 Mixed | 73 | 52.5 % |
 Anxiety disorders | 27 | 19.4 % |
 Insomnia | 23 | 16.5 % |
 Panic disorders | 16 | 11.5 % |